210 related articles for article (PubMed ID: 12459383)
1. HIF-1A, pimonidazole, and iododeoxyuridine to estimate hypoxia and perfusion in human head-and-neck tumors.
Janssen HL; Haustermans KM; Sprong D; Blommestijn G; Hofland I; Hoebers FJ; Blijweert E; Raleigh JA; Semenza GL; Varia MA; Balm AJ; van Velthuysen ML; Delaere P; Sciot R; Begg AC
Int J Radiat Oncol Biol Phys; 2002 Dec; 54(5):1537-49. PubMed ID: 12459383
[TBL] [Abstract][Full Text] [Related]
2. Tumour cell proliferation under hypoxic conditions in human head and neck squamous cell carcinomas.
Wijffels KI; Marres HA; Peters JP; Rijken PF; van der Kogel AJ; Kaanders JH
Oral Oncol; 2008 Apr; 44(4):335-44. PubMed ID: 17689286
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia and perfusion measurements in human tumors--initial experience with pimonidazole and IUdR.
Begg AC; Janssen H; Sprong D; Hofland I; Blommestijn G; Raleigh JA; Varia M; Balm A; Van Velthuyzen L; Delaere P; Sciot R; Haustermans KMG
Acta Oncol; 2001; 40(8):924-8. PubMed ID: 11845956
[TBL] [Abstract][Full Text] [Related]
4. Comparison between pimonidazole binding, oxygen electrode measurements, and expression of endogenous hypoxia markers in cancer of the uterine cervix.
Jankovic B; Aquino-Parsons C; Raleigh JA; Stanbridge EJ; Durand RE; Banath JP; MacPhail SH; Olive PL
Cytometry B Clin Cytom; 2006 Mar; 70(2):45-55. PubMed ID: 16456867
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia in human colorectal adenocarcinoma: comparison between extrinsic and potential intrinsic hypoxia markers.
Goethals L; Debucquoy A; Perneel C; Geboes K; Ectors N; De Schutter H; Penninckx F; McBride WH; Begg AC; Haustermans KM
Int J Radiat Oncol Biol Phys; 2006 May; 65(1):246-54. PubMed ID: 16618579
[TBL] [Abstract][Full Text] [Related]
6. Metabolic markers in relation to hypoxia; staining patterns and colocalization of pimonidazole, HIF-1α, CAIX, LDH-5, GLUT-1, MCT1 and MCT4.
Rademakers SE; Lok J; van der Kogel AJ; Bussink J; Kaanders JH
BMC Cancer; 2011 May; 11():167. PubMed ID: 21569415
[TBL] [Abstract][Full Text] [Related]
7. Correlation and colocalization of HIF-1α and pimonidazole staining for hypoxia in laryngeal squamous cell carcinomas: A digital, single-cell-based analysis.
Swartz JE; Smits HJG; Philippens MEP; de Bree R; H A M Kaanders J; Willems SM
Oral Oncol; 2022 May; 128():105862. PubMed ID: 35447566
[TBL] [Abstract][Full Text] [Related]
8. Colocalization of carbonic anhydrase 9 expression and cell proliferation in human head and neck squamous cell carcinoma.
Hoogsteen IJ; Marres HA; Wijffels KI; Rijken PF; Peters JP; van den Hoogen FJ; Oosterwijk E; van der Kogel AJ; Kaanders JH
Clin Cancer Res; 2005 Jan; 11(1):97-106. PubMed ID: 15671533
[TBL] [Abstract][Full Text] [Related]
9. Erythropoietin receptor is not a surrogate marker for tumor hypoxia and does not correlate with survival in head and neck squamous cell carcinomas.
Hoogsteen IJ; Peeters WJ; Marres HA; Rijken PF; van den Hoogen FJ; van der Kogel AJ; Kaanders JH
Radiother Oncol; 2005 Aug; 76(2):213-8. PubMed ID: 16112214
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia-inducible factor 1alpha expression as an intrinsic marker of hypoxia: correlation with tumor oxygen, pimonidazole measurements, and outcome in locally advanced carcinoma of the cervix.
Hutchison GJ; Valentine HR; Loncaster JA; Davidson SE; Hunter RD; Roberts SA; Harris AL; Stratford IJ; Price PM; West CM
Clin Cancer Res; 2004 Dec; 10(24):8405-12. PubMed ID: 15623619
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of hypoxia-inducible factor-1alpha (HIF-1alpha) as an intrinsic marker of tumor hypoxia in U87 MG human glioblastoma: in vitro and xenograft studies.
Vordermark D; Brown JM
Int J Radiat Oncol Biol Phys; 2003 Jul; 56(4):1184-93. PubMed ID: 12829158
[TBL] [Abstract][Full Text] [Related]
12. Hypoxia in relation to vasculature and proliferation in liver metastases in patients with colorectal cancer.
van Laarhoven HW; Kaanders JH; Lok J; Peeters WJ; Rijken PF; Wiering B; Ruers TJ; Punt CJ; Heerschap A; van der Kogel AJ
Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):473-82. PubMed ID: 16242253
[TBL] [Abstract][Full Text] [Related]
13. Pimonidazole binding and tumor vascularity predict for treatment outcome in head and neck cancer.
Kaanders JH; Wijffels KI; Marres HA; Ljungkvist AS; Pop LA; van den Hoogen FJ; de Wilde PC; Bussink J; Raleigh JA; van der Kogel AJ
Cancer Res; 2002 Dec; 62(23):7066-74. PubMed ID: 12460928
[TBL] [Abstract][Full Text] [Related]
14. Dysregulation of hypoxia inducible factor-1alpha in head and neck squamous cell carcinoma cell lines correlates with invasive potential.
Cohen NA; Lai SY; Ziober AF; Ziober BL
Laryngoscope; 2004 Mar; 114(3):418-23. PubMed ID: 15091212
[TBL] [Abstract][Full Text] [Related]
15. Overexpression and nuclear translocation of hypoxia-inducible factor prolyl hydroxylase PHD2 in head and neck squamous cell carcinoma is associated with tumor aggressiveness.
Jokilehto T; Rantanen K; Luukkaa M; Heikkinen P; Grenman R; Minn H; Kronqvist P; Jaakkola PM
Clin Cancer Res; 2006 Feb; 12(4):1080-7. PubMed ID: 16489060
[TBL] [Abstract][Full Text] [Related]
16. Proliferation and hypoxia in human squamous cell carcinoma of the cervix: first report of combined immunohistochemical assays.
Kennedy AS; Raleigh JA; Perez GM; Calkins DP; Thrall DE; Novotny DB; Varia MA
Int J Radiat Oncol Biol Phys; 1997 Mar; 37(4):897-905. PubMed ID: 9128967
[TBL] [Abstract][Full Text] [Related]
17. Correlation of [18F]FMISO autoradiography and pimonidazole [corrected] immunohistochemistry in human head and neck carcinoma xenografts.
Troost EG; Laverman P; Philippens ME; Lok J; van der Kogel AJ; Oyen WJ; Boerman OC; Kaanders JH; Bussink J
Eur J Nucl Med Mol Imaging; 2008 Oct; 35(10):1803-11. PubMed ID: 18421457
[TBL] [Abstract][Full Text] [Related]
18. Differentiation-associated staining with anti-pimonidazole antibodies in head and neck tumors.
Janssen HL; Hoebers FJ; Sprong D; Goethals L; Williams KJ; Stratford IJ; Haustermans KM; Balm AJ; Begg AC
Radiother Oncol; 2004 Jan; 70(1):91-7. PubMed ID: 15036858
[TBL] [Abstract][Full Text] [Related]
19. Reduced expression of hypoxia-inducible factor-1alpha in perinecrotic regions of solid tumors.
Sobhanifar S; Aquino-Parsons C; Stanbridge EJ; Olive P
Cancer Res; 2005 Aug; 65(16):7259-66. PubMed ID: 16103077
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical detection of osteopontin in advanced head-and-neck cancer: prognostic role and correlation with oxygen electrode measurements, hypoxia-inducible-factor-1alpha-related markers, and hemoglobin levels.
Bache M; Reddemann R; Said HM; Holzhausen HJ; Taubert H; Becker A; Kuhnt T; Hänsgen G; Dunst J; Vordermark D
Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1481-7. PubMed ID: 17056190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
